| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | -50.2% |
| SG&A Expense | $2.2M | +4.1% |
| Operating Income | -$3.2M | +23.3% |
| Net Income | -$3.1M | +24.4% |
| EPS (Basic) | -$2.65 | +45.1% |
| EPS (Diluted) | -$2.65 | +45.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5.8M | +50.1% |
| Total Assets | $5.8M | +50.1% |
| Current Liabilities | $419K | +10.8% |
| Total Liabilities | $419K | +10.8% |
| Stockholders' Equity | $5.4M | +54.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | +34.8% |
| Financing Cash Flow | $4.7M | +6.3% |